(SSNC) SS&C Technologies Holdings - Ratings and Ratios
Portfolio, Trading, Reconciliation, Healthcare, Advisory
SSNC EPS (Earnings per Share)
SSNC Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 20.6% |
| Value at Risk 5%th | 32.3% |
| Reward | |
|---|---|
| Sharpe Ratio | 0.54 |
| Alpha Jensen | -2.55 |
| Character | |
|---|---|
| Hurst Exponent | 0.485 |
| Beta | 1.203 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.72% |
| Mean DD | 5.98% |
Description: SSNC SS&C Technologies Holdings October 16, 2025
SS&C Technologies Holdings, Inc. (NASDAQ: SSNC) delivers a broad suite of software and software-enabled services to the financial services and healthcare sectors, covering the full transaction lifecycle-from front-office trading and modeling to middle-office portfolio management and back-office accounting, reconciliation, compliance, and tax reporting. The firm also provides healthcare solutions such as claims adjudication, benefit management, and care-management analytics, alongside professional consulting, implementation, and ongoing support services. Its global footprint spans North America, Europe, the Middle East, Africa, and the Asia-Pacific.
According to the FY 2023 Form 10-K, SS&C reported revenue of roughly $5.5 billion, representing a 5 % year-over-year increase driven primarily by growth in its SaaS subscription base (annual recurring revenue up 12 %). The company serves over 30,000 institutional clients, with an operating margin of about 22 %, reflecting the scalability of its cloud-native platform. Key sector drivers include accelerating regulatory compliance spending in asset management, continued migration of legacy on-premise systems to cloud solutions, and heightened demand for data-analytics tools to meet ESG reporting requirements.
If you want a data-rich, side-by-side comparison of SSNC’s valuation multiples, growth trends, and competitive positioning, the ValueRay platform provides a transparent dashboard that can help deepen your analysis.
SSNC Stock Overview
| Market Cap in USD | 20,918m |
| Sub-Industry | Application Software |
| IPO / Inception | 1996-05-31 |
| Return 12m vs S&P 500 | 0.23% |
| Analyst Rating | 4.33 of 5 |
SSNC Dividends
| Dividend Yield | 1.20% |
| Yield on Cost 5y | 1.64% |
| Yield CAGR 5y | 16.61% |
| Payout Consistency | 100.0% |
| Payout Ratio | 21.7% |
SSNC Growth Ratios
| CAGR | 19.47% |
| CAGR/Max DD Calmar Ratio | 0.86 |
| CAGR/Mean DD Pain Ratio | 3.26 |
| Current Volume | 900.1k |
| Average Volume | 1561.6k |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (852.0m TTM) > 0 and > 6% of Revenue (6% = 368.9m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 2.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.02% (prev 11.64%; Δ -2.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.56b > Net Income 852.0m (YES >=105%, WARN >=100%) |
| Net Debt (6.42b) to EBITDA (2.13b) ratio: 3.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (253.1m) change vs 12m ago -0.39% (target <= -2.0% for YES) |
| Gross Margin 48.56% (prev 49.08%; Δ -0.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.42% (prev 31.26%; Δ 1.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.27 (EBITDA TTM 2.13b / Interest Expense TTM 439.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.69
| (A) 0.03 = (Total Current Assets 5.32b - Total Current Liabilities 4.77b) / Total Assets 19.49b |
| (B) 0.21 = Retained Earnings (Balance) 4.05b / Total Assets 19.49b |
| (C) 0.08 = EBIT TTM 1.43b / Avg Total Assets 18.96b |
| (D) 0.30 = Book Value of Equity 3.75b / Total Liabilities 12.50b |
| Total Rating: 1.69 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.18
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 5.94% = 2.97 |
| 3. FCF Margin 26.40% = 6.60 |
| 4. Debt/Equity 0.98 = 2.04 |
| 5. Debt/Ebitda 3.01 = -1.78 |
| 6. ROIC - WACC (= 0.51)% = 0.64 |
| 7. RoE 12.54% = 1.04 |
| 8. Rev. Trend 98.44% = 7.38 |
| 9. EPS Trend -4.25% = -0.21 |
What is the price of SSNC shares?
Over the past week, the price has changed by -0.58%, over one month by +5.18%, over three months by -0.66% and over the past year by +16.15%.
Is SS&C Technologies Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SSNC is around 83.21 USD . This means that SSNC is currently overvalued and has a potential downside of -2.39%.
Is SSNC a buy, sell or hold?
- Strong Buy: 6
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SSNC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101.2 | 18.7% |
| Analysts Target Price | 101.2 | 18.7% |
| ValueRay Target Price | 92.5 | 8.5% |
SSNC Fundamental Data Overview November 06, 2025
P/E Trailing = 25.4362
P/E Forward = 13.4771
P/S = 3.4022
P/B = 3.0808
P/EG = 0.9232
Beta = 1.203
Revenue TTM = 6.15b USD
EBIT TTM = 1.43b USD
EBITDA TTM = 2.13b USD
Long Term Debt = 6.99b USD (from longTermDebt, last fiscal year)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 6.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.42b USD (from netDebt column, last quarter)
Enterprise Value = 27.33b USD (20.92b + Debt 6.81b - CCE 390.8m)
Interest Coverage Ratio = 3.27 (Ebit TTM 1.43b / Interest Expense TTM 439.0m)
FCF Yield = 5.94% (FCF TTM 1.62b / Enterprise Value 27.33b)
FCF Margin = 26.40% (FCF TTM 1.62b / Revenue TTM 6.15b)
Net Margin = 13.86% (Net Income TTM 852.0m / Revenue TTM 6.15b)
Gross Margin = 48.56% ((Revenue TTM 6.15b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 47.69% (prev 47.95%)
Tobins Q-Ratio = 1.40 (Enterprise Value 27.33b / Total Assets 19.49b)
Interest Expense / Debt = 1.53% (Interest Expense 104.2m / Debt 6.81b)
Taxrate = 17.13% (43.5m / 253.9m)
NOPAT = 1.19b (EBIT 1.43b * (1 - 17.13%))
Current Ratio = 1.12 (Total Current Assets 5.32b / Total Current Liabilities 4.77b)
Debt / Equity = 0.98 (Debt 6.81b / totalStockholderEquity, last quarter 6.93b)
Debt / EBITDA = 3.01 (Net Debt 6.42b / EBITDA 2.13b)
Debt / FCF = 3.95 (Net Debt 6.42b / FCF TTM 1.62b)
Total Stockholder Equity = 6.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.37% (Net Income 852.0m / Total Assets 19.49b)
RoE = 12.54% (Net Income TTM 852.0m / Total Stockholder Equity 6.80b)
RoCE = 10.40% (EBIT 1.43b / Capital Employed (Equity 6.80b + L.T.Debt 6.99b))
RoIC = 8.70% (NOPAT 1.19b / Invested Capital 13.65b)
WACC = 8.20% (E(20.92b)/V(27.72b) * Re(10.45%) + D(6.81b)/V(27.72b) * Rd(1.53%) * (1-Tc(0.17)))
Discount Rate = 10.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.20%
[DCF Debug] Terminal Value 69.81% ; FCFE base≈1.39b ; Y1≈1.37b ; Y5≈1.43b
Fair Price DCF = 70.54 (DCF Value 17.21b / Shares Outstanding 244.0m; 5y FCF grow -1.72% → 3.0% )
EPS Correlation: -4.25 | EPS CAGR: 11.63% | SUE: 1.15 | # QB: 1
Revenue Correlation: 98.44 | Revenue CAGR: 5.93% | SUE: 1.02 | # QB: 2
Additional Sources for SSNC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle